Header Logo

Connection

EVELYNE M LOYER to Middle Aged

Back to Details
This is a "connection" page, showing publications EVELYNE M LOYER has written about Middle Aged.
EVELYNE M LOYER
Connection Strength
0.261
Middle Aged
  1. (18)F-FDG Uptake at the Surgical Margin after Hepatic Resection: Patterns of Uptake and Differential Diagnosis. Eur Radiol. 2015 Aug; 25(8):2453-9.
    View in: PubMed
    Score: 0.019
  2. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol. 2013 Oct; 201(4):W582-9.
    View in: PubMed
    Score: 0.018
  3. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol. 2010 Sep; 34(9):1287-94.
    View in: PubMed
    Score: 0.014
  4. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009 Dec 02; 302(21):2338-44.
    View in: PubMed
    Score: 0.014
  5. Radiographic appearance of the chest following therapy for Hodgkin disease. Eur J Radiol. 2000 Aug; 35(2):136-48.
    View in: PubMed
    Score: 0.007
  6. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study. Radiology. 1999 Sep; 212(3):866-75.
    View in: PubMed
    Score: 0.007
  7. Tumor thrombus in the venous drainage pathways of primary, recurrent and metastatic disease on routine oncologic imaging studies: beyond hepatocellular and renal cell carcinomas. Br J Radiol. 2019 Jun; 92(1098):20180478.
    View in: PubMed
    Score: 0.007
  8. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. Radiother Oncol. 2019 04; 133:54-61.
    View in: PubMed
    Score: 0.006
  9. Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2019 Jan; 26(1):275-281.
    View in: PubMed
    Score: 0.006
  10. The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia. J Natl Cancer Inst. 2018 08 01; 110(8):888-894.
    View in: PubMed
    Score: 0.006
  11. Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470. N Engl J Med. 1998 Apr 02; 338(14):991-2.
    View in: PubMed
    Score: 0.006
  12. Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Gut. 2018 06; 67(6):1095-1102.
    View in: PubMed
    Score: 0.006
  13. Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence. J Comput Assist Tomogr. 2017 Jul/Aug; 41(4):607-613.
    View in: PubMed
    Score: 0.006
  14. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016 11; 22(11):1294-1302.
    View in: PubMed
    Score: 0.005
  15. Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. Abdom Imaging. 1996 May-Jun; 21(3):202-6.
    View in: PubMed
    Score: 0.005
  16. Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma. J Gastrointest Surg. 2016 Apr; 20(4):741-7.
    View in: PubMed
    Score: 0.005
  17. Imaging of superficial soft-tissue infections: sonographic findings in cases of cellulitis and abscess. AJR Am J Roentgenol. 1996 Jan; 166(1):149-52.
    View in: PubMed
    Score: 0.005
  18. Importance of dynamic assessment of the soft tissues in the sonographic diagnosis of echogenic superficial abscesses. J Ultrasound Med. 1995 Sep; 14(9):669-71.
    View in: PubMed
    Score: 0.005
  19. RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases. Ann Surg Oncol. 2015 Mar; 22(3):834-842.
    View in: PubMed
    Score: 0.005
  20. Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer. Ann Diagn Pathol. 2014 Oct; 18(5):266-70.
    View in: PubMed
    Score: 0.005
  21. Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Br J Haematol. 2014 Oct; 167(2):177-84.
    View in: PubMed
    Score: 0.005
  22. Efficacy and safety of portal vein embolization for two-stage hepatectomy in patients with colorectal liver metastasis. J Vasc Interv Radiol. 2014 Apr; 25(4):608-17.
    View in: PubMed
    Score: 0.004
  23. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
    View in: PubMed
    Score: 0.004
  24. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013 Jun; 257(6):1079-88.
    View in: PubMed
    Score: 0.004
  25. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012 Dec 20; 30(36):4566-72.
    View in: PubMed
    Score: 0.004
  26. Case 177: Congenital absence of the portal vein with hepatic adenomatosis. Radiology. 2012 Jan; 262(1):364-7.
    View in: PubMed
    Score: 0.004
  27. Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg. 2011 Jul; 98(7):1003-9.
    View in: PubMed
    Score: 0.004
  28. Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? Cancer. 2011 Oct 01; 117(19):4484-92.
    View in: PubMed
    Score: 0.004
  29. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011 Mar 10; 29(8):1083-90.
    View in: PubMed
    Score: 0.004
  30. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol. 2010 May 20; 28(15):2549-55.
    View in: PubMed
    Score: 0.003
  31. Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma. J Clin Oncol. 2009 Nov 01; 27(31):5213-8.
    View in: PubMed
    Score: 0.003
  32. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007 Nov; 94(11):1386-94.
    View in: PubMed
    Score: 0.003
  33. Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging. 2007 Sep-Oct; 32(5):660-7.
    View in: PubMed
    Score: 0.003
  34. Radiologic findings in taxane induced colitis. Eur J Radiol. 2008 Apr; 66(1):75-8.
    View in: PubMed
    Score: 0.003
  35. Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol. 2006 Oct 28; 12(40):6556-8.
    View in: PubMed
    Score: 0.003
  36. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006 May; 141(5):460-6; discussion 466-7.
    View in: PubMed
    Score: 0.003
  37. Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma. Leuk Lymphoma. 2006 Mar; 47(3):481-5.
    View in: PubMed
    Score: 0.003
  38. Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging. 2006 Sep-Oct; 31(5):568-74.
    View in: PubMed
    Score: 0.003
  39. Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma. Cancer. 2005 Aug 15; 104(4):781-7.
    View in: PubMed
    Score: 0.003
  40. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005 May; 241(5):715-22, discussion 722-4.
    View in: PubMed
    Score: 0.002
  41. Transdiaphragmatic radiofrequency ablation of liver tumors. J Am Coll Surg. 2004 Nov; 199(5):826-9.
    View in: PubMed
    Score: 0.002
  42. Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease. Clin Cancer Res. 2004 Aug 15; 10(16):5432-8.
    View in: PubMed
    Score: 0.002
  43. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004 Apr; 239(4):450-8.
    View in: PubMed
    Score: 0.002
  44. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res. 2004 Apr 01; 10(7):2319-26.
    View in: PubMed
    Score: 0.002
  45. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol. 2004 Mar; 182(3):619-23.
    View in: PubMed
    Score: 0.002
  46. Use of thin-section, multidetector row helical CT images for coronal oblique reformations for optimal visualization of structures in the hepatoduodenal ligament. Abdom Imaging. 2004 Mar-Apr; 29(2):231-8.
    View in: PubMed
    Score: 0.002
  47. A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan. Cancer Chemother Pharmacol. 2004 Jan; 53(1):1-7.
    View in: PubMed
    Score: 0.002
  48. Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer. Gynecol Oncol. 2003 Sep; 90(3):552-9.
    View in: PubMed
    Score: 0.002
  49. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002 Mar; 8(3):233-40.
    View in: PubMed
    Score: 0.002
  50. Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer. 2001 Nov 01; 92(9):2327-33.
    View in: PubMed
    Score: 0.002
  51. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics. 2001 Oct; 21 Spec No:S41-54.
    View in: PubMed
    Score: 0.002
  52. Metastases to the pancreas from renal cell carcinoma: findings on three-phase contrast-enhanced helical CT. AJR Am J Roentgenol. 1999 Jun; 172(6):1555-9.
    View in: PubMed
    Score: 0.002
  53. A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer. Anticancer Drugs. 1999 Apr; 10(4):375-83.
    View in: PubMed
    Score: 0.002
  54. Patterns of uterine enhancement with helical CT. Eur J Radiol. 1998 Oct; 28(3):250-5.
    View in: PubMed
    Score: 0.002
  55. Carcinoma en cuirasse: uncontrolled local recurrence of breast carcinoma after transverse rectus abdominis myocutaneous flap reconstruction. AJR Am J Roentgenol. 1997 Sep; 169(3):914-5.
    View in: PubMed
    Score: 0.001
  56. A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. Clin Cancer Res. 1997 Sep; 3(9):1501-5.
    View in: PubMed
    Score: 0.001
  57. An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs. 1997 Aug; 8(7):657-61.
    View in: PubMed
    Score: 0.001
  58. Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Clin Cancer Res. 1996 Aug; 2(8):1285-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.